DuPont de Nemours (DD) Earnings Expected to Grow: Should You Buy?

DuPont de Nemours (DD) is expected to report Q2 2025 earnings on August 5, with consensus forecasting EPS of $1.06 (+9.3% YoY) and revenues of $3.22 billion (+1.4% YoY). Despite a 1.35% upward revision in EPS estimates over the past 30 days and a history of four consecutive earnings beats, the company's current Zacks Earnings ESP of -0.62% and a Zacks Rank #3 suggest that a positive earnings surprise is not strongly indicated, implying potential uncertainty regarding post-release stock movement.

Analysis

DuPont de Nemours (DD) presents a mixed pre-earnings profile for its quarter ending June 2025. Consensus estimates project year-over-year growth, with earnings per share (EPS) expected to rise 9.3% to $1.06 and revenue to increase 1.4% to $3.22 billion. Supporting a positive outlook, the consensus EPS estimate has been revised upward by 1.35% in the last 30 days, and the company has a strong history of delivering positive earnings surprises for the past four consecutive quarters, including an 8.42% beat in the last reported period. However, this is counterbalanced by more recent, bearish analyst sentiment, reflected in a negative Zacks Earnings ESP of -0.62%, which indicates the most recent estimates are below the consensus. This negative ESP, combined with a neutral Zacks Rank #3 (Hold), makes it difficult to conclusively predict an earnings beat. In contrast, industry peer LyondellBasell (LYB) faces a significantly more challenging environment, with forecasts for a 61.2% plunge in EPS and a 29.9% drop in revenue, highlighting DuPont's relative operational stability within the diversified chemicals sector.

Key Decisions for Investors

• Given the conflicting signals of positive historical performance against a negative short-term surprise predictor, investors should exercise caution ahead of the August 5th earnings release, as the probability of a significant earnings beat is not strongly indicated.
• Focus should be placed on management's forward-looking guidance and discussion of business conditions during the earnings call, as this will likely be more influential for the stock's sustained trajectory than a marginal beat or miss on headline numbers.
• The starkly negative outlook for peer LyondellBasell (LYB) relative to DuPont's projected growth could present a potential pairs trade opportunity for investors looking to capitalize on DD's relative strength within a challenged sector.
• For those considering a new position, the current uncertainty may warrant waiting for a potential post-earnings pullback or for clear confirmation of fundamental strength from the company's outlook before committing capital.